Communication of benefit-risk information: an online randomised controlled trial
Communication of benefits and harms of treatments: an online randomised controlled trial.
How benefits and harms information of medical interventions is communicated affects how well patients understand it and can impact their decision-making and confidence.
What is the CICERO trial
The CICERO study is a randomised controlled trial that compares three different ways of communicating available information on medical interventions: "Summary of Findings table", "Kilim plot/table" and "Vitruvian plot".
Participants in the study will be randomised to one of these three communication tools and then answer some questions. The study is all online, completed in a single session lasting about 20 minutes.
Please note that you must be aged 18 to 65 years old to participate in this study.
The results will hopefully improve how benefit-harm information is communicated to patients, supporting their informed participation in clinical shared decision-making.
TAKE PART IN THE TRIAL
If you would like to participate, please read the Participant Information Sheet.
When you have carefully read the Participant Information Sheet and feel ready, click on the following link to start:
We are proudly collaborating with organisations, associations and patient-led initiatives that are supporting recruitment for the CICERO trial.